These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 25203595)
21. Frequency of the CCR5-delta32 allele in Brazilian populations: A systematic literature review and meta-analysis. Silva-Carvalho WH; de Moura RR; Coelho AV; Crovella S; Guimarães RL Infect Genet Evol; 2016 Sep; 43():101-7. PubMed ID: 27208805 [TBL] [Abstract][Full Text] [Related]
22. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis. Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738 [TBL] [Abstract][Full Text] [Related]
23. Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Silversides JA; Heggarty SV; McDonnell GV; Hawkins SA; Graham CA Mult Scler; 2004 Apr; 10(2):149-52. PubMed ID: 15124759 [TBL] [Abstract][Full Text] [Related]
24. CCR5-Δ32 gene polymorphism is associated with retinopathy in patients with type 1 diabetes. Słomiński B; Ławrynowicz U; Myśliwska J; Ryba-Stanisławowska M; Skrzypkowska M; Brandt A Mol Cell Endocrinol; 2017 Jan; 439():256-260. PubMed ID: 27619405 [TBL] [Abstract][Full Text] [Related]
25. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients. Melum E; Karlsen TH; Broomé U; Thorsby E; Schrumpf E; Boberg KM; Lie BA Tissue Antigens; 2006 Jul; 68(1):78-81. PubMed ID: 16774544 [TBL] [Abstract][Full Text] [Related]
26. The CCR5-Delta32 Genetic Polymorphism and HIV-1 Infection Susceptibility: a Meta-analysis. Ni J; Wang D; Wang S Open Med (Wars); 2018; 13():467-474. PubMed ID: 30426084 [TBL] [Abstract][Full Text] [Related]
27. Association of chemokine receptor 5 (CCR5) delta32 mutation with Behçet's disease is dependent on gender in Iranian patients. Mojtahedi Z; Ahmadi SB; Razmkhah M; Azad TK; Rajaee A; Ghaderi A Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S91-4. PubMed ID: 17067435 [TBL] [Abstract][Full Text] [Related]
28. CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia. Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Schirin-Sokhan R; Gartung C; Lorenzen J; Matern S; Lammert F J Mol Med (Berl); 2004 Jan; 82(1):64-9. PubMed ID: 14673528 [TBL] [Abstract][Full Text] [Related]
29. Lack of association between chemokine receptor 5 (CCR5) δ32 mutation and pathogenesis of asthma in Iranian patients. Abousaidi H; Vazirinejad R; Arababadi MK; Rafatpanah H; Pourfathollah AA; Derakhshan R; Daneshmandi S; Hassanshahi G South Med J; 2011 Jun; 104(6):422-5. PubMed ID: 21886032 [TBL] [Abstract][Full Text] [Related]
30. Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis. Contopoulos-Ioannidis DG; O'Brien TR; Goedert JJ; Rosenberg PS; Ioannidis JP J Acquir Immune Defic Syndr; 2003 Jan; 32(1):70-6. PubMed ID: 12514416 [TBL] [Abstract][Full Text] [Related]
31. CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease. Atzeni F; Boiardi L; Casali B; Farnetti E; Nicoli D; Sarzi-Puttini P; Pipitone N; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Filippini D; Paolazzi G; Salvarani C Rheumatology (Oxford); 2012 Dec; 51(12):2141-5. PubMed ID: 22966075 [TBL] [Abstract][Full Text] [Related]
32. The delta32 allele distribution of the CCR5 gene and its relationship with certain cancers in a Turkish population. Degerli N; Yilmaz E; Bardakci F Clin Biochem; 2005 Mar; 38(3):248-52. PubMed ID: 15708547 [TBL] [Abstract][Full Text] [Related]
33. Association between chemokine receptor 5 (CCR5) delta32 gene variant and atherosclerosis: a meta-analysis of 13 studies. Zhang Z; Liu J; Wang H; Wu H; Wu X; Dong J; Liao L Int J Clin Exp Med; 2015; 8(1):658-65. PubMed ID: 25785041 [TBL] [Abstract][Full Text] [Related]
34. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis. Brajão de Oliveira K; Reiche EM; Kaminami Morimoto H; Pelegrinelli Fungaro MH; Estevão D; Pontello R; Franco Nasser T; Watanabe MA J Cutan Pathol; 2007 Jan; 34(1):27-32. PubMed ID: 17214851 [TBL] [Abstract][Full Text] [Related]
35. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS; AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692 [TBL] [Abstract][Full Text] [Related]
36. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633 [TBL] [Abstract][Full Text] [Related]
37. Genetic variations in CC chemokine receptors and hypertension. Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193 [TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of myocardial infarction among Tunisian male patients. Kallel A; Abdessalem S; Sédiri Y; Mourali MS; Feki M; Mechmeche R; Jemaa R; Kaabachi N Clin Biochem; 2012 Apr; 45(6):420-4. PubMed ID: 22285384 [TBL] [Abstract][Full Text] [Related]
39. The association between Li J; Peng Y; Liu H; Wu Q Oncotarget; 2017 Oct; 8(47):82796-82802. PubMed ID: 29137303 [TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients. Zheng B; Wiklund F; Gharizadeh B; Sadat M; Gambelunghe G; Hallmans G; Dillner J; Wallin KL; Ghaderi M Anticancer Res; 2006; 26(5B):3669-74. PubMed ID: 17094383 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]